ADENOSINE DEAMINASE DECREASED

This adverse event was reported 7 times

These drugs are most commonly taken by patients reporting ADENOSINE DEAMINASE DECREASED:

# Drug Count
0 ADALIMUMAB 4
1 ETRASIMOD 4
2 INFLIXIMAB 4
3 METHOTREXATE 4
4 METHOTREXATE SODIUM 4
5 PREDNISONE 4
6 USTEKINUMAB 4
7 VEDOLIZUMAB 4
8 ADALIMUMAB-ADAZ 2
9 ELAPEGADEMASE-LVLR 1
See all common drugs associated with ADENOSINE DEAMINASE DECREASED

ADENOSINE DEAMINASE DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELAPEGADEMASE-LVLR 1 0.0033
1 ETRASIMOD 4 0.0024
2 VEDOLIZUMAB 4 0.0000
3 USTEKINUMAB 4 0.0000
4 ADALIMUMAB-ADAZ 2 0.0000
5 INFLIXIMAB 4 0.0000
6 METHOTREXATE SODIUM 4 0.0000
7 PREDNISONE 4 0.0000
8 ADALIMUMAB 4 0.0000
See all drugs enriched for association with ADENOSINE DEAMINASE DECREASED

ADENOSINE DEAMINASE DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Integrin Receptor Antagonist [EPC] 4 0.0000
1 Interleukin-12 Antagonist [EPC] 4 0.0000
2 Interleukin-23 Antagonist [EPC] 4 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
4 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
5 Corticosteroid [EPC] 4 0.0000
See all drug classes enriched for association with ADENOSINE DEAMINASE DECREASED